Skip to main content
LOGO(small) - Queen's University Belfast
  • Our twitter
  • Our
  • Our
  • Our
SEARCH SEARCH
LOGO(large) - Queen's University Belfast

Centre for Public Health

  • Home
  • About
    • About Us
    • Education
    • Find a PhD Supervisor
  • Research
    • Cancer Epidemiology
    • Epidemiology & Public Health
    • Health Services & Global Health
    • Nutrition
  • Events
  • News
  • Contact Us
    • Staff
  • Related Links
  • Home
  • About
    • About Us
    • Education
    • Find a PhD Supervisor
  • Research
    • Cancer Epidemiology
    • Epidemiology & Public Health
    • Health Services & Global Health
    • Nutrition
  • Events
  • News
  • Contact Us
    • Staff
  • Related Links
  • Our twitter
  • Our
  • Our
  • Home
  • Centre for Public Health
  • News

News

Centre for Public Health researcher awarded prestigious Future Leader Fellowships by UKRI

23 April, 2020

Dr. Úna McMenamin has been awarded Future Leaders Fellowships as part of a new investment announced today by UK Research and Innovation (UKRI).

Dr Úna McMenamin from the Centre for Public Health, received an award of over £883,000 to develop one of the first population-based registers for the precursor condition of the most commonly diagnosed gynaecological cancer. The research will use routinely collected health records to improve diagnostics and treatment while leading to improved clinical guidelines on a global scale.

Dr Úna McMenamin
Dr Úna McMenamin

Endometrial cancer, also referred to as womb cancer, is the most commonly diagnosed gynaecological cancer in the UK and is rapidly rising in incidence, especially in younger women. There is no routine screening for endometrial cancer and primary treatment involves a hysterectomy, meaning a woman is forced to lose her fertility if treatment is required. Endometrial hyperplasia is a recognised precursor, which if detected, can help to prevent the disease progressing to endometrial cancer.

Dr. McMenamin, whose research will provide the first population-based endometrial hyperplasia register in Europe, explains: “The current lack of data and information around this common cancer is alarming. I am delighted to have the opportunity to address this through establishing a register in Northern Ireland that will enable novel data linkages to important clinical datasets allowing us to identify the women most at risk of progression to endometrial cancer. The register will be facilitated by the Northern Ireland Cancer Registry, which is funded by the Northern Ireland Public Health Agency.

“This research programme will generate robust population-level evidence to inform diagnostic, treatment and surveillance guidelines for women with endometrial hyperplasia and endometrial cancer and will ultimately lead to better informed clinical decision-making between women and their health care professionals.”


Share
Latest News
  • New study explores how we can better design healthier cities
    2 June, 2020
  • Centre for Public Health researcher awarded prestigious Future Leader Fellowships by UKRI
    23 April, 2020
  • Coronavirus research - How to ensure emerging and existing evidence is accessible.
    1 April, 2020
  • Joint Public Health Conference – Innovation in Public Health
    2 December, 2019
  • Queen's researchers recognised as most influential researchers who study diabetes complications
    11 February, 2019
In This Section
Home
  • Home
  • About
  • Research
  • Events
  • News
  • Contact Us
  • Related Links
Queen's University Belfast - Logo (small)
Contact Us

Centre for Public Health
Institute of Clinical Sciences
Royal Victoria Hospital
Belfast
BT12 6BA

Phone: +44 (0) 28 9097 6350

Quick Links

  • Home
  • Research
  • About

 

© Queen's University Belfast 2021
Legal
Accessibility Statement
Privacy and Cookies
Modern Slavery Statement